Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database.
about
Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomesEvidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in manIdentifying plausible adverse drug reactions using knowledge extracted from the literatureRisks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.Examining the safety of PPAR agonists - current trends and future prospects.
P2860
Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Drug safety of rosiglitazone a ...... ch PharmacoVigilance database.
@ast
Drug safety of rosiglitazone a ...... ch PharmacoVigilance database.
@en
type
label
Drug safety of rosiglitazone a ...... ch PharmacoVigilance database.
@ast
Drug safety of rosiglitazone a ...... ch PharmacoVigilance database.
@en
prefLabel
Drug safety of rosiglitazone a ...... ch PharmacoVigilance database.
@ast
Drug safety of rosiglitazone a ...... ch PharmacoVigilance database.
@en
P2860
P50
P356
P1476
Drug safety of rosiglitazone a ...... ch PharmacoVigilance database.
@en
P2093
Stephanie Berthet
P2860
P356
10.1186/1472-6904-11-5
P577
2011-05-24T00:00:00Z